Desmoid Fibromatosis: Clinical Trials

3 trials for Desmoid Fibromatosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 2, Completed 1

Follow Desmoid Fibromatosis: new trials by email Literature Review of Desmoid Fibromatosis trials Research Report on Desmoid Fibromatosis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery
Biospecimen Collection, Computed Tomography, Echocardiography Test - Desmoid Fibromatosis, Recurrent Desmoid Fibromatosis
Phase 2Active not recruitingChildren's Oncology Group312020-10-072026-10-01
Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis
Drug Eluting Bead Embolization (DEB) for Desmoid Fibromatosis - Desmoid, Desmoid Fibromatosis of Skin
Phase 2CompletedRabin Medical Center82018-10-112022-03-25
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Biospecimen Collection, Computed Tomography, Echocardiography Test - Acinar Cell Carcinoma, Adenoid Cystic Carcinoma
Phase 2Active not recruitingNational Cancer Institute (NCI)7982017-01-302026-06-17

Narrower conditions

Desmoid Tumors (3)  ·  Adenocarcinoma, Bronchiolo-Alveolar (1)  ·  Adenocarcinoma, Mucinous (1)  ·  Adrenocortical Carcinoma (1)  ·  Bile Duct Neoplasms (1)  ·  Carcinoma, Acinar Cell (1)  ·  Carcinoma, Adenoid Cystic (1)  ·  Carcinoma, Basal Cell (1)  ·  Carcinoma, Endometrioid (1)  ·  Carcinoma, Giant Cell (1)  ·  Carcinoma, Transitional Cell (1)  ·  Carcinosarcoma (1)  ·  Cholangiocarcinoma (1)  ·  Chordoma (1)  ·  Cystadenocarcinoma, Mucinous (1)

Broader conditions

Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Connective Tissue (3)  ·  Neoplasms, Connective and Soft Tissue (3)  ·  Neoplasms, Fibrous Tissue (3)  ·  Fibroma (2)  ·  Adenocarcinoma (1)  ·  Adenocarcinoma of Lung (1)  ·  Adnexal Diseases (1)  ·  Adrenal Cortex Diseases (1)  ·  Adrenal Cortex Neoplasms (1)  ·  Adrenal Gland Diseases (1)  ·  Adrenal Gland Neoplasms (1)  ·  Bile Duct Diseases (1)  ·  Biliary Tract Diseases (1)

Interventions

Magnetic Resonance Spectroscopy (2)  ·  Specimen Handling (2)  ·  CTLA-4 Antigen (1)  ·  Ipilimumab (1)  ·  Nivolumab (1)  ·  Phantoms, Imaging (1)  ·  X-Rays (1)  ·  nirogacestat (1)

Sponsors

Children's Oncology Group (1)  ·  National Cancer Institute (NCI) (1)  ·  Rabin Medical Center (1)

Countries

United States (2)  ·  Australia (1)  ·  Canada (1)  ·  Guam (1)  ·  Israel (1)  ·  New Zealand (1)  ·  Puerto Rico (1)

Top investigators

Fariba Navid (1)  ·  Sandip P Patel (1)

Results publications

PMID 31969335, PMID 33362722, PMID 33882143, PMID 34380663, PMID 34716198, PMID 38243705, PMID 38358334, PMID 39067873, PMID 39343510, PMID 39417692, PMID 39583952, PMID 39856213, PMID 40402690, PMID 40588371, PMID 41672597, PMID 41892875, PMID 41995270, PMID 42499790

NIH funding

U10CA180886 (1), U10CA180888 (1)